Terelizumab
Showing 1 - 4 of 4
Colon Cancer, Immunotherapy Trial in Chongqing (Terelizumab, CapeOx)
Not yet recruiting
- Colon Cancer
- Immunotherapy
- Terelizumab
- CapeOx
-
Chongqing, ChinaDaping hospital
Apr 16, 2023
Immunotherapy, Gastric Cancer, Rectal Cancer Trial (Terelizumab, CapeOx, Trastuzumab)
Not yet recruiting
- Immunotherapy
- +4 more
- Terelizumab
- +3 more
- (no location specified)
Aug 24, 2022
Urothelial Carcinoma Trial in Shanghai (AZD4547, Tislelizumab)
Recruiting
- Urothelial Carcinoma
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 8, 2023
Locally Advanced Rectal Carcinoma, Circulating Tumor DNA Trial in Beijing (circulating tumor DNA)
Recruiting
- Locally Advanced Rectal Carcinoma
- Circulating Tumor DNA
- circulating tumor DNA
-
Beijing, Beijing, ChinaDepartment of General Surgery, Peking Union Medical College Hosp
Oct 27, 2022